TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 46 filers reported holding TG THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $15,511,000 | +27.7% | 2,003,991 | 0.0% | 0.14% | +11.0% |
| Q2 2016 | $12,144,000 | -28.9% | 2,003,991 | 0.0% | 0.13% | -29.4% |
| Q1 2016 | $17,074,000 | -28.6% | 2,003,991 | 0.0% | 0.18% | -9.1% |
| Q4 2015 | $23,908,000 | +18.4% | 2,003,991 | 0.0% | 0.20% | +5.9% |
| Q3 2015 | $20,200,000 | -39.2% | 2,003,991 | 0.0% | 0.19% | -36.0% |
| Q2 2015 | $33,246,000 | +4.7% | 2,003,991 | -2.3% | 0.29% | +10.6% |
| Q1 2015 | $31,739,000 | -2.3% | 2,050,313 | 0.0% | 0.26% | -20.2% |
| Q4 2014 | $32,477,000 | +48.5% | 2,050,313 | 0.0% | 0.33% | +19.9% |
| Q3 2014 | $21,877,000 | +7.8% | 2,050,313 | -5.1% | 0.28% | +10.8% |
| Q2 2014 | $20,291,000 | +36.1% | 2,160,965 | 0.0% | 0.25% | +31.1% |
| Q1 2014 | $14,911,000 | +73.8% | 2,160,965 | -1.8% | 0.19% | +57.0% |
| Q4 2013 | $8,579,000 | +183.7% | 2,199,656 | +266.6% | 0.12% | +181.4% |
| Q3 2013 | $3,024,000 | – | 600,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |